<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>
  <head>
    <meta content="text/html; charset=windows-1252"
      http-equiv="Content-Type">
    <title>Alex Sava, et al. -- Prion disinfection solution</title>
  </head>
  <body>
    <div style="margin-left: 40px; text-align: center;" align="left"><span
        style="font-weight: bold;"><br>
      </span>
      <div align="left"><span style="font-weight: bold;"><img
            style="width: 124px; height: 82px;" alt="" src="0logo.gif"></span><br>
        <span style="font-weight: bold;"> <a href="../index.htm">rexresearch.com</a></span><br>
      </div>
    </div>
    <div style="margin-left: 40px;">
      <hr style="width: 100%; height: 2px;"><br style="font-weight:
        bold;">
      <div style="text-align: center;"><big><big><span
              style="font-weight: bold;">Alex SAVA </span><br
              style="font-weight: bold;">
            <br style="font-weight: bold;">
            <span style="font-weight: bold;">Prion Disinfection</span><br
              style="font-weight: bold;">
          </big></big></div>
      <br>
      <hr style="width: 100%; height: 2px;">
      <div style="text-align: center;"><span style="font-weight: bold;"></span><br>
        <script type="text/javascript"><!--
google_ad_client = "pub-2924514667432343";
google_ad_width = 728;
google_ad_height = 90;
google_ad_format = "728x90_as";
google_ad_type = "text_image";
//2007-01-05: http://www.rexresearch.com
google_ad_channel = "5682237150";
//--></script>
        <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script><br>
        <script type="text/javascript"><!--
google_ad_client = "pub-2924514667432343";
google_ad_width = 728;
google_ad_height = 90;
google_ad_format = "728x90_as";
google_ad_type = "text_image";
//2007-01-05: http://www.rexresearch.com
google_ad_channel = "5682237150";
//--></script>
        <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script><br>
        <script type="text/javascript"><!--
google_ad_client = "pub-2924514667432343";
google_ad_width = 728;
google_ad_height = 90;
google_ad_format = "728x90_as";
google_ad_type = "text_image";
//2007-01-05: http://www.rexresearch.com
google_ad_channel = "5682237150";
//--></script>
        <script type="text/javascript" src="http://pagead2.googlesyndication.com/pagead/show_ads.js">
</script><span style="font-weight: bold;"></span></div>
      <hr style="width: 100%; height: 2px;"><span style="font-weight:
        bold;"><br>
        <a
          href="http://www.sciencealert.com.au/news/20091310-19987-2.html">http://www.sciencealert.com.au/news/20091310-19987-2.html</a></span><br
        style="font-weight: bold;">
      <br style="font-weight: bold;">
      <div style="text-align: center;"><big><span style="font-weight:
            bold;">New Steriliser to Save Lives</span></big><br>
      </div>
      <br>
      13 October 2009<br>
      University of Melbourne<br>
      <br>
      Australian researchers have created a solution to deactivate
      prions, which are rogue, infectious proteins that cause
      Creutzfeldt-Jacob disease (CJD) and can be transmitted via
      surgical instruments.<br>
      <br>
      Novapharm Research (Australia) Pty Ltd, in collaboration with the
      University of Melbourne, has developed solutions which break up
      and deactivate the rogue protein molecules of CJD.<br>
      <br>
      The outcome is cost effective, will enable all medical instruments
      to be treated against prions, will not disrupt current surgical
      procedures and is easily incorporated into current cleaning
      protocols.<br>
      <br>
      The importance of this is that CJD and other prion diseases have
      no known cure and can have a lengthy symptom-free incubation
      period of decades.<br>
      <br>
      The human prion is resistant to both heat and chemicals and is
      reported to be up to a hundred thousand times more difficult to
      deactivate than the animal form of infective agent which causes
      well known diseases in cattle, such as mad cow disease, and
      scrapie in sheep.<br>
      <br>
      Any error in identifying a CJD-carrier can be fatal and costly -
      many hospitals around the world have been forced to destroy
      millions of dollars worth of instruments when patients were
      diagnosed with CJD some time after undergoing routine eye and
      neurosurgical procedures.<br>
      <br>
      A further factor limiting decontamination from prions is that
      existing cleaning protocols are damaging to medical instruments
      such as flexible endoscopes and some instruments used in
      neurosurgical, dental and opthalmological procedures.<br>
      <br>
      It is estimated that currently less than&nbsp; one per cent of
      medical instruments are treated against prions, with hospital
      procedures relying on staff to identify potential carriers.<br>
      <br>
      The treatment process was optimised and performed by a research
      team in the Department of Pathology at the University of Melbourne
      led by Dr Victoria Lawson. The University of Melbourne is
      Australia’s leading prion disease research centre.<br>
      <br>
      Novapharm’s prion deactivating solutions have been approved by the
      Australian Therapeutic Goods Administration and have full CE
      certification for distribution in the European Union.<br>
      <br>
      According to Mr Steve Kritzler, a director of Novapharm, there
      should be widespread interest from hospitals around the world in a
      solution that can deactivate prions on all medical instruments,
      including flexible endoscopes.<br>
      <br>
      “This solution fills a gaping hole in current infection control
      practices which basically rely on hospital staff identifying ‘high
      risk patients’ of these diseases which don’t have obvious
      symptoms,” Mr Kritzler said.<br>
      <br>
      “The new instrument reprocessing solutions developed by Novapharm
      can also be cost effective for hospitals, GPs, dentists, and vets
      since they will work with existing cleaning equipment and are
      highly effective as a general pre-cleaner compatible with any
      surgical or medical instruments.<br>
      <br>
      “We expect hospitals in the UK to be particularly interested in
      our solution since it has been the location for a number of CJD
      incidents in the past,” Mr Kritzler added.<br>
      <br>
      The commercial formulations will be sold in Australia under trade
      names Asepti RAPIDZYME Pr and Asepti AUTOZYME Pr.<br>
      <br>
      The solutions are derived from naturally occurring enzymes which
      have been specifically formulated to attack the structure of
      prions while maintaining characteristics which allow use as a
      general pre-cleaner of surgical and medical instruments. <br>
      <br>
      <hr style="width: 100%; height: 2px;"><br>
      <a
        href="http://www.internetchemie.info/news/2008/jun08/index-en.html"><span
          style="font-weight: bold;">http://www.internetchemie.info/news/2008/jun08/index-en.html</span></a><br
        style="font-weight: bold;">
      <span style="font-weight: bold;">Chemistry News Archive 2008 -
        June</span><br>
      <br>
      Physics - Fundamental Research. Non-magnetic lattice - Credit:
      Sava Denev .... Prions are not degraded by conventional sewage
      treatment processes ...<br>
      <br>
      <hr style="width: 100%; height: 2px;"><br>
      <div style="text-align: center;"><big><span style="font-weight:
            bold;">Patents</span><br style="font-weight: bold;">
        </big></div>
      <br style="font-weight: bold;">
      <span style="font-weight: bold;">WO02/062400</span><br
        style="font-weight: bold;">
      <span style="font-weight: bold;">PRION DISINFECTION</span><br>
      Applicants: NOVAPHARM RESEARCH (AUSTRALIA) PTY LTD, et al.<br>
      Inventors: KRITZLER, Steven; (AU); SAVA, Alex; (AU); ZALUNARDO,
      Michael; (AU).<br>
      <span style="font-weight: bold;">Abstract</span>: The invention
      relates to a methods and compositions for treating a surface,
      suspension or solution contaminated with a PrP^Sc prion protein or
      a surrogate thereof. The methods and compositions employ a
      combination of one or more enzymes effective to cleave a prion
      protein to fragments having a non-infective molecular weight, and
      one or more agents selected to favour conformational unfolding of
      the PrP^Sc prion protein while not denaturing the one or more
      enzymes.<span style="font-weight: bold;"></span><br>
      <span style="font-weight: bold;"><br>
        EP1370303</span><br style="font-weight: bold;">
      <span style="font-weight: bold;">PRION DISINFECTION</span><br>
      Kritzler, Steven (AU); Sava, Alex (AU); Zalunardo, Michael (AU)<br>
      Publication Date: 12/17/2003<br>
      Assignee: NOVAPHARM RES PTY LTD (AU)<br>
      International Classes: A61B19/00; A61B19/00; A01N63/00; A01N63/00;
      A61L2/00; A61L2/00; A61L2/02; A61L2/02; A61L2/025; A61L2/08;
      A61L2/08; A61L2/16; A61L2/16; C12S5/00; C12S5/00; C12S9/00;
      C12S9/00; (IPC1-7): A61L2/26; A01N41:02; A01N41/02; A01N41/04;
      A01N41/10; A01N63/00; A61L2/00; A61L2/025; A61L2/08; A61L2/16;
      A01N41:04; A01N41:10; A01N63/00<br>
      European Classes: A01N63/00; A61L2/00P4; A61L2/025; A61L2/08;
      A61L2/16<br>
      <br>
      <span style="font-weight: bold;">AU2002227785</span><br
        style="font-weight: bold;">
      <span style="font-weight: bold;">Prion disinfection</span><br>
      Inventor:&nbsp; SAVA ALEX ; ZALUNARDO MICHAEL<br>
      Applicant:&nbsp; NOVAPHARM RES AUSTRALIA<br>
      2006-12-21<br>
      <br>
      <span style="font-weight: bold;">AU2005100872</span><br
        style="font-weight: bold;">
      <span style="font-weight: bold;">Prion disinfection</span><br
        style="font-weight: bold;">
      Inventor:&nbsp; SAVA ALEX ; KRITZLER STEVEN<br>
      Applicant:&nbsp; NOVAPHARM RES AUSTRALIA<br>
      2005-11-17<br>
      <br>
      <hr style="width: 100%; height: 2px;"><br>
      <div align="center"><img alt="" src="0logo.gif" height="82"
          width="124"><br>
        <br>
      </div>
      <div style="text-align: center;"><b>Your Support Maintains this
          Service -- </b><b><br>
        </b> <b><br>
        </b> <b>BUY</b><b><br>
        </b> <b><br>
        </b> <big><b>The</b><b> Rex Research Civilization Kit </b></big><b><br>
        </b> <b><br>
        </b> <b>... It's Your Best Bet &amp; Investment in Sustainable
          Humanity on Earth ... </b><b><br>
        </b><b> Ensure &amp; Enhance Your Survival &amp; Genome
          Transmission ...</b><b> </b><b><br>
        </b> <b>Everything @ rexresearch.com on a Data DVD ! </b><b><br>
        </b> <b><br>
        </b> <b><a href="order.htm"
            ">ORDER PAGE</a></b><b><br>
        </b> </div>
      <b> </b><b><br>
      </b><b> </b>
      <hr style="width: 62%; height: 2px;">
      <script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
      <script type="text/javascript">
try{
var pageTracker = _gat._getTracker("UA-xxxxxx-x");
pageTracker._trackPageview();
} catch(err) {}
</script>
      <script type="text/javascript">
var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
</script>
      <script type="text/javascript">
try{
var pageTracker = _gat._getTracker("UA-xxxxxx-x");
pageTracker._trackPageview();
} catch(err) {}
</script></div>
  </body>
</html>
